The U.S. Food and Drug Administration (FDA) has agreed to allowing restricted use of the irritable bowel syndrome (IBS) medication Zelnorm. In March 2007, Zelnorm was taken off the market due to studies that suggested the med increased the risk of heart attack and stroke. But the FDA says it will permit use of the medication for certain female patients who suffer from IBS with constipation.